Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06232564
Title A Study of Etoposide-carboplatin in Combination With Pembrolizumab and Lenvatinib Maintenance in HG-NETs (PELICAN)
Acronym PELICAN
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Imperial College London
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR

Facility Status City State Zip Country Details
Imperial College Healthcare NHS Trust RECRUITING London W12 0HS United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field